ArticleInternal medicine (Tokyo, Japan)2019

Bacteriologically Determined De Novo Tuberculosis during Tumor Necrosis Factor-α Inhibitor Therapy.

Gen Takahashi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.